JS001 Combination Therapy in NSCLC Negative Driving Gene After First-line Chemotherapy.
Clinical trial NCT04459663 · UNKNOWN
Trial details
- NCT number
- NCT04459663
- Sponsor
- Li Zhang, MD
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-31
- Primary completion
- 2023-09-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.